reference/32763059

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32763059

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, U.S. Gov't, P.H.S.
endingPage	1522
issn	0021-9738
issueIdentifier	10
pageRange	1513-1522
publicationName	The Journal of clinical investigation
startingPage	1513
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5aab2aac005a3f22298c6c4e73eb2293 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d278880d3e4b9cee089799e853e9fe3e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ff177fc2f68b94ff64c68aabb1ba311f
bibliographicCitation	Barry-Lane PA, Patterson C, van der Merwe M, Hu Z, Holland SM, Yeh ET, Runge MS. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest. 2001 Nov;108(10):1513–22. PMID: 11714743; PMCID: PMC209414.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0e72ffd86f17b1104eb09a5a0412b199 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_729838a3b6b5e186db9aa0b7ab7d7723 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6914d0ded05ce2e59ac07f81603994ce http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a6b4f12cab9374c91cac23cdf071449 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf91df4095e15d62113488ad0a119006 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8b2e9c2711a8bd0129d01956f67ca40 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c4748ae43dba5e4863256afee70b4f5
date	2001-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/11714743 https://doi.org/10.1172/jci11927 https://doi.org/10.1172/jci200111927 https://pubmed.ncbi.nlm.nih.gov/PMC209414
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4632 https://portal.issn.org/resource/ISSN/0021-9738
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice
discusses	http://id.nlm.nih.gov/mesh/M0028676 http://id.nlm.nih.gov/mesh/M0026397 http://id.nlm.nih.gov/mesh/M0027090 http://id.nlm.nih.gov/mesh/M0016705 http://id.nlm.nih.gov/mesh/M0001601 http://id.nlm.nih.gov/mesh/M0497067
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001161Q000503 http://id.nlm.nih.gov/mesh/D001057Q000502 http://id.nlm.nih.gov/mesh/D010750Q000502
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008810 http://id.nlm.nih.gov/mesh/D001057Q000235 http://id.nlm.nih.gov/mesh/D001161Q000378 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D019255 http://id.nlm.nih.gov/mesh/D009131Q000473 http://id.nlm.nih.gov/mesh/D017382 http://id.nlm.nih.gov/mesh/D001161Q000235 http://id.nlm.nih.gov/mesh/D017931 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D001483 http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D002455Q000502
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10898 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_46ac4caca5d4f75b201ae4da1d525db8 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359597 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1511c19481c95166fe4a45c393b142cb http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d22ef8d03375d89409872210d728cfc0 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4c6dae7397bbd9431da887f4e5681417

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13058 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11816 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136210299 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID17969

Total number of triples: 62.